Article
The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2005
Hayes Vanessa M, Severi Gianluca, Eggleton Sarah A, Padilla Emma J D, Southey Melissa C, Sutherland Robert L, Hopper John L, Giles Graham G
Abstract excerpt
The androgen receptor (AR) gene encodes a transcription factor, which mediates androgen action in target tissues, including the prostate. Prostate cancer is androgen dependent, implicating AR in susceptibility to this male condition. Male pattern balding, androgenetic alopecia, has recently been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.